Status:
COMPLETED
Identification of Novel Circadian Biomarkers
Lead Sponsor:
Northwestern University
Conditions:
Circadian Rhythm Disorders
Eligibility:
All Genders
18-60 years
Brief Summary
Circadian clocks are not only found in discrete areas of the brain, but are found in virtually every organ in our bodies, including the heart, lungs and immune system. Disruptions in circadian clocks,...
Detailed Description
Circadian clocks are not only found in discrete areas of the brain, but are found in virtually every organ in our bodies, including the heart, lungs and immune system. Disruptions in circadian clocks,...
Eligibility Criteria
Inclusion
- Healthy controls
- Age 18-60
- Intermediate circadian chronotype as determined by the Horne-Ostberg and Munich questionnaire
- Habitual sleep start times between 9:30pm and 1am
- Habitual sleep duration of 6-9 hours
Exclusion
- History or current Diagnostic and Statistical Manual-V major psychiatric disorder
- Use of psychoactive medications
- Beck Depression inventory ≥ 16 indicating possible depression
- A history or current diagnosis of a primary sleep disorder (insomnia, sleep apnea, circadian rhythm sleep disorder, restless legs)
- Shift work or other types of self-imposed irregular sleep/wake cycles
- History of, or concurrent unstable or serious medical illness
- Allergy to heparin
- Blindness or other visual impairment other than glasses
Key Trial Info
Start Date :
January 29 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2017
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT02291003
Start Date
January 29 2015
End Date
September 30 2017
Last Update
August 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611